STIM
Neuronetics Inc
NASDAQ: STIM · HEALTHCARE · MEDICAL DEVICES
$1.51
-10.90% today
Updated 2026-06-03
Market cap
$89.77M
P/E ratio
—
P/S ratio
0.59x
EPS (TTM)
$-0.54
Dividend yield
—
52W range
$1 – $5
Volume
2.5M
Neuronetics Inc (STIM) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.51
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$10.20
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -24.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.